Science Explorer Back to mapMap
Discussion
Company · Tromsø · Norway

Biotec Pharmacon (Norway)

biotec.noROR OpenAlex
Research works
4
fractional, all time
Citations
169
41.4 per fractional work
Top-10% rate
33.3%
all institutions 10.0%
Open access
47%
world 40%
International
22%
world 18%
Biotec Pharmacon (Norway)

Not ranked overall: Biotec Pharmacon (Norway) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Biotec Pharmacon (Norway) work in?

In all years, 57% of research at Biotec Pharmacon (Norway) is in Life Sciences, 35% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (35%), Medicine (28%), Agricultural and Biological Sciences (15%). It does 1.5× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 57.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 35.0% of its workAgricultural and Biological Sciences: 1 fractional works · 15.0% of its workImmunology and Microbiology: 0 fractional works · 7.5% of its workHealth Sciences: 1 fractional works · 35.0% of its workMedicine: 1 fractional works · 27.5% of its workHealth Professions: 0 fractional works · 5.0% of its workDentistry: 0 fractional works · 2.5% of its workPhysical Sciences: 0 fractional works · 7.5% of its workEngineering: 0 fractional works · 2.5% of its workEnvironmental Science: 0 fractional works · 2.5% of its workMaterials Science: 0 fractional works · 2.5% of its workALL ITS WORKBiotec Pharmacon(Norway)4fractional works, all years
Life Sciences57%Physical Sciences8%Health Sciences35%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 9 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology135.0%
    2. Agricultural and Biological Sciences115.0%
    3. Immunology and Microbiology07.5%
    1. Medicine127.5%
    2. Health Professions05.0%
    3. Dentistry02.5%
    1. Engineering02.5%
    2. Environmental Science02.5%
    3. Materials Science02.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Biotec Pharmacon (Norway)?

The most cited paper from Biotec Pharmacon (Norway) is "The effect of soluble β-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood" (Charlotte Sissener Engstad, Rolf Einar Engstad, Jan-Ole Olsen et al., 2002), with 122 citations. Next come "The structure of uracil-DNA glycosylase from Atlantic cod (Gadus morhua) reveals cold-adaptation features" (66) and "Macrophage stimulating agent soluble yeast β‐1,3/1,6‐glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo‐controlled phase II study" (66).

Most cited papers
#PaperReleasedCitations
1 The effect of soluble β-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood Charlotte Sissener Engstad, Rolf Einar Engstad, Jan-Ole Olsen et al. · International Immunopharmacology Oct 2002 122
2 The structure of uracil-DNA glycosylase from Atlantic cod (Gadus morhua) reveals cold-adaptation features Ingar Leiros, Elin Moe, Olav Lanes et al. · Acta Crystallographica Section D Biological Crystallography 22 Jul 2003 66
3 Macrophage stimulating agent soluble yeast β‐1,3/1,6‐glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo‐controlled phase II study Svetlana N. Zykova, Ksenia A Balandina, Наталья Владимировна Ворохобина et al. · Journal of Diabetes Investigation Open access 2 Dec 2013 66
4 Soluble β‐1,3/1,6‐glucan from yeast inhibits experimental periodontal disease in Wistar rats Torbjørn Jarle Breivik, Per Kristian Opstad, Rolf Einar Engstad et al. · Journal Of Clinical Periodontology 29 Mar 2005 41
5 Optimisation of the Surface Electrostatics as a Strategy for Cold Adaptation of Uracil-DNA N-glycosylase (UNG) from Atlantic Cod (Gadus morhua) Elin Moe, Ingar Leiros, Ellen Kristin Riise et al. · Journal of Molecular Biology 16 Sep 2004 32
All 9 most cited papers, with filters and sorting

Which research topics does Biotec Pharmacon (Norway) publish most on?

By volume in 2022-now: Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Pneumocystis jirovecii pneumonia detection and treatment.

Antibiotic Resistance in…0Antibiotic Resistance in Bacteria: 0 fractional worksAntibiotics Pharmacokine…0Antibiotics Pharmacokinetics and Efficacy: 0 fractional worksPneumocystis jirovecii p…0Pneumocystis jirovecii pneumonia detection and treatment: 0 fractional works
Molecular MedicinePharmacologyEpidemiology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  2. 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  3. 3 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.9%not open53.1%

World: 40% of research is openly available.

with international co-authors22.4%domestic only77.6%

World: 18% is written across borders.

How has Biotec Pharmacon (Norway)'s research output changed?

2005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tromsø

All research institutions in Tromsø

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Biotec Pharmacon (Norway). Posts are plain text and can be reported.